Commentary

Video

NeuroOp Guru: Can a dead nerve swell?

Andrew G. Lee, MD, and Drew Carey, MD, return for this latest episode of the NeuroOp Guru to discuss whether a dead nerve can swell, focusing on the condition of papilledema caused by elevated intracranial pressure.

This latest episode of the NeuroOp Guru—hosted by Andrew G. Lee, MD, from Houston Methodist, and joined by Drew Carey, MD, from Johns Hopkins University—explores whether atrophic optic nerves can exhibit swelling or thickening in patients with recurrent papilledema. Carey explains that papilledema can be due to various conditions, including idiopathic intracranial hypertension, hydrocephalus, or brain tumors, and that recurrent headaches may indicate increased pressure. A retrospective study1 of 165 patients with papilledema found that 63% experienced at least one relapse, with 50% showing recurrent papilledema. OCT scans were crucial in detecting these relapses, even in atrophic nerves, suggesting that OCT remains a valuable tool in monitoring neurological conditions. Carey stresses the importance of OCT in detecting intracranial pressure changes in atrophic nerves, contrasting it with glaucoma management. The episode concludes with a proposed revised adage: “A dead nerve can't swell, but it can thicken.”

Reference
  1. Xie JS, Donaldson L, Margolin EA. Swelling of atrophic optic discs in idiopathic intracranial hypertension. J Neuroophthalmol. 2024;44(2):212-218. doi:10.1097/WNO.0000000000001932

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.